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Abstract
Background: Insulators and domain boundaries both shield genes from adjacent enhancers and inhibit intrusion of
heterochromatin into transgenes. Previous studies examined the functional mechanism of the MYC insulator element MINE
and its CTCF binding sites in the context of transgenes that were randomly inserted into the genome by transfection.
However, the contribution of CTCF binding sites to both gene regulation and maintenance of chromatin has not been
tested at the endogenous MYC gene.
Methodology/Principal Findings: To determine the impact of CTCF binding on MYC expression, a series of mutant human
chromosomal alleles was prepared in homologous recombination-efficient DT40 cells and individually transferred by
microcell fusion into murine cells. Functional tests reported here reveal that deletion of CTCF binding elements within the
MINE does not impact the capacity of this locus to correctly organize an ‘accessible’ open chromatin domain, suggesting
that these sites are not essential for the formation of a competent, transcriptionally active locus. Moreover, deletion of the
CTCF site at the MYC P2 promoter reduces transcription but does not affect promoter acetylation or serum-inducible
transcription. Importantly, removal of either CTCF site leads to DNA methylation of flanking sequences, thereby contributing
to progressive loss of transcriptional activity.
Conclusions: These findings collectively demonstrate that CTCF-binding at the human MYC locus does not repress
transcriptional activity but is required for protection from DNA methylation.
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Introduction
Insulator and boundary elements shield genomic loci from
unscheduled transcriptional activation or repression by regulatory
elements. In higher eukaryotes, the majority of insulator elements
bind to the highly conserved zinc-finger protein CTCF which has
been shown to mediate diverse regulatory functions including
promoter activation and repression, gene silencing, insulation, and
imprinting [1,2].
Recent genome-wide surveys have demonstrated that CTCF is
uniquely distributed throughout the genome in a pattern distinct
from general transcription factors [3,4]. These studies have
revealed that the majority of CTCF binding sites are located far
from gene promoters with only one fifth of CTCF binding sites
mapping within 2 kb of transcription initiation sites. Interestingly,
promoter-proximal CTCF-binding sites generally correlate with
low gene activity [4], consistent with previous reports that CTCF
can repress transcription [5,6].
CTCF repressor activity was first described for the MYC gene.
The arrangement of CTCF-binding sites within the human MYC
gene is one of the notable exceptions to the general genomic pattern
outlined above.ThemammalianMYCgene is embedded ina gene-
poor environment within an extensive region of condensed
chromatin, which is bordered on either side by matrix-associated
elements. A constitutive CTCF binding site, associated with a
DNAse I hypersensitive region, termed MINE (MYC insulator
element), is able to act as an insulator in stably transfected cell lines
[7]. The CTCF-binding site within the MINE (site N, Figure 1) is
coincident with the boundary of hyperacetylation of the MYC
promoter. This arrangement suggested that CTCF functions as a
barrier for the MYC locus by the formation and/or maintenance of
chromatin structure required for normal MYC gene expression. In
addition to CTCF site N, an additional constitutive CTCF-binding
site (site A,Figure 1)is located close to the transcriptional start site of
theMYCP2promoter.Deletionofsite A inatransientlytransfected
MYC reporter gene construct has been reported to relieve
suppression of MYC promoter activity [6].
Although the exact mechanism through which CTCF impacts
transcriptional activity remains elusive, previous data suggest that
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to mediate the formation of inter- and intra-chromosomal loops
[8]. Insulator-mediated formation of chromatin loop structures has
been demonstrated in both Drosophila and mammalian cell types
(reviewed in [9,10]). For example, allele-specific binding of CTCF
to the imprinting control region of the IGF2/H19 gene locus
mediates the allele-specific interaction of promoters with regula-
tory elements on different chromosomal locations [11,12]. This
allele-specific interaction is thought to activate and silence the
paternal and maternal IGF2 allele, respectively.
Conceptually, the multiple roles for CTCF in gene
regulation could be due to its ability to mediate chromatin
loops [10,13]. Indeed, the formation of reversible chromatin
loops through regulatory proteins can block the activity of the
viral SV40 enhancer [14]. While present data suggest an
essential role for CTCF in nuclear organization, the majority
of its effects on transcription were derived from analyses using
CTCF sites outside of their naturally occurring chromatin
domain.
Given the potential significance of the CTCF-binding arrange-
ment at the MYC promoter, we have determined the conse-
quences of CTCF binding site deletions at the human MYC gene
in the context of the complete human chromosome. These data
indicate that CTCF is required for normal MYC expression.
Deletion of CTCF sites N and A at this locus results in reduced
expression of the MYC gene. Reduced transcription correlates
with an increase in levels of DNA methylation within the promoter
and around the deleted CTCF binding sites. These data are
inconsistent with a role for CTCF as a transcriptional repressor of
MYC expression, and support previously proposed models in
which CTCF is essential for protecting gene domains from DNA
methylation.
Results
Deletion of CTCF binding sequences at the MYC gene by
homologous recombination
The MYC insulator element MINE serves as an efficient
boundary and insulator element for both transfected and
randomly integrated reporter-gene constructs [7]. To test whether
CTCF is essential for the insulator function of MINE, we
engineered targeted deletions within the MYC locus on human
chromosome 8 using the recombination-efficient cell line DT40
[15]. In order to examine the consequence of CTCF binding site
deletions in mammalian cells, the recombined human chromo-
somes were subsequently transferred into murine B78 cells by
microcell fusion.
We created three different deletions within the MYC insulator
and promoter regions (Figure 1A). A large 2.3 kb deletion (DLg)
removed sequences from 1.4 kb to 3.7 kb upstream of the P2
transcription initiation site, including the entire MINE and
additional flanking sequences. To further elucidate the role of
CTCF in chromatin insulation at the MYC locus, we generated
two smaller deletions DCTCF-N and DCTCF-NA (163 bp and
54 bp, respectively) that removed CTCF binding sites either
within the MINE region or within both the MINE and the MYC
promoter (Figure 1A).
To confirm that these deletion alleles eliminate CTCF binding,
we performed ChIP analysis using chromatin isolated from B78
cell lines containing wildtype or mutated MYC alleles. Quantita-
tive PCR analyses confirmed that the wildtype human MYC allele
–after transfer into murine B78 cells - binds CTCF at both the
MINE and the P2 proximal promoter (Figure 1B). In contrast,
targeted deletion of CTCF binding sites N and A in human MYC
alleles (DCTCF-N and DCTCF-NA) predictably abolished
Figure 1. Structure of recombinant human MYC alleles containing deletions in CTCF binding regions. (A) Schematic outline of the
wildtype human MYC gene with its three exons (dark filled bars), the MYC insulator element MINE and the positions of CTCF binding site N and A.
Black arrows indicate transcriptional start sites of the P1 and P2 MYC promoters. Depicted below are the promoter regions deleted in MYC alleles
DLg, DCTCF-N and DCTCF-NA. (B) ChIP analysis of CTCF binding at the wildtype and mutant human and mouse MYC alleles. Bars show the fold
enrichment of CTCF binding sequences relative to the enrichment of b-globin sequences. While CTCF binding is detectable at the wildtype (wt)
human MYC allele, a 163 bp deletion at site N (DCTCF-N) and a 54 bp deletion at site A (DCTCF-NA) abrogate binding. In mock immunoprecipitations
(ctrl, without antibody), none of the CTCF-binding sequences is enriched. Enrichment of CTCF site N is not analyzed (NA) in the mutant DLg as
sequences for the primer set used is deleted.
doi:10.1371/journal.pone.0006109.g001
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P2 promoter-proximal site occurs independently of CTCF-binding
within the MINE. CTCF site A of the MYC P2 promoter region
remains associated with CTCF even after loss of CTCF binding at
site N. These data do not preclude the possibility that each of these
sites independently recruit CTCF, but act in concert to regulate
transcription.
MYC adopts an active chromatin structure upon transfer
into murine B78 cells
To determine whether any of the deleted DNA elements at the
boundary of the MYC domain are required for the establishment
or maintenance of transcriptionally active or inactive chromatin
structures, we compared the degree of histone modification at
human MYC alleles relative to the homologous allele residing in
chicken DT40 and murine cells. ChIP-analysis of chromatin
prepared from DT40 cells containing the human chromosome 8
[DT40(hc8)] revealed that the human MYC promoter displayed a
21-fold lower level of histone H3 acetylation compared to the
transcriptional start site of the active chicken MYC promoter
(Figure 2, upper graph). In contrast to the hypoacetylated status in
chicken cells, the human MYC P2 gene promoter adopts an active
configuration after transfer of human chromosome 8 into mouse
B78 cells. In these cells, hyperacetylation of histones at the human
MYC promoter is similar to that of the mouse MYC promoter,
within a twofold range (Figure 2, lower graph). Hyperacetylation
of histone H3 is detectable across an extended region of the
wildtype human MYC gene, peaking at the upstream promoter
region detected by primer set K (Figure 3) and at the transcription
start sites of the P1 and P2 promoters (primer set N, Figure 3),
analogous to our observations in human Jurkat and HL60 cell
types [7]. With increasing distance from the transcription initiation
sites, H3 acetylation decreases and is barely detectable within exon
3 and 2.3 kb upstream of exon 1 (primer sets R and L,
respectively, in Figure 3). Primer sets that detect sequences further
upstream of 22.3.kb and downstream of exon 3 did not detect any
enrichment of H3 acetylation (data not shown). Together these
data demonstrate that, in contrast to observations in chicken host
cells, the human MYC allele on chromosome 8 adopts its normal
chromatin configuration when transferred into murine host cells.
The MYC insulator element does not affect
hyperacetylation of the MYC chromatin domain
The addition of MINE to transgene constructs leads to an
increase in transgene expression after integration into various
genomic regions [7]. This result raises the question of whether
MINE – in its native context - contributes to the maintenance of
hyperacetylation in the MYC promoter region by inhibiting the
silencing influence of flanking heterochromatin. To test this
hypothesis, we used our panel of deletions within the upstream
region of the MYC gene and defined the extent of histone
acetylation. We performed ChIP analyses on both wildtype and
mutant MYC alleles [wt, DLg, DCTCF-N, and DCTCF-NA]
residing in murine B78 cells (Figure 3). Surprisingly, we found that
the pattern of histone acetylation shows little if any change upon
deletion of upstream regions. The promoter regions of all clones
were hyperacetylated despite the deletion of sequences within the
MINE and beyond. The DLg mutant allele - comprising an
extensive 2.3 kb deletion surrounding the MINE – also generated
a pattern comparable to the wild type allele (Figure 3). The level of
histone hyperacetylation that is detected by primer set K remained
unaffected, despite deletion of MINE and juxtaposition to
sequences associated with hypoacetylated, ‘‘silent’’ chromatin.
This suggests that the establishment of the hyperacetylated domain
and the position of the boundary are mediated by promoter-
proximal chromatin remodeling complexes that induce histone
acetylation over a defined distance from the promoter.
In combination, these experiments demonstrate that targeted
deletions of MINE and/or CTCF do not disrupt or increase the
establishment of hyperacetylated chromatin at the MYC gene.
Removal of the putative boundary by a deletion of upstream
sequences as large as 2.3 kb (DLg) did not prevent or affect
acetylation over the promoter, nor did deletion of any or both
CTCF binding sites (CTCF-N and CTCF-NA influence the
overall pattern of histone acetylation.
Figure 2. Acetylation status of the MYC locus on human
chromosome 8 residing in chicken DT40 cells and in murine
B78 cells. DNA recovered from chromatin immunoprecipitations with
antibodies specific for lysine9/14 acetylated histone H3 (H3K9/14ac)
was subjected to duplex PCR using primers specific for the human,
chicken and mouse MYC genes. The enrichment of these regions in the
immunoprecipitated DNA was normalized to the signal detected with
primers specific for the endogenous chicken b-globin gene or the
mouse b-globin. Upper graph, comparison of histone acetylation levels
at the human MYC promoter regions L, K, N and the chicken MYC
promoter region in DT40 cells. Primer location and CTCF sites N and A
of the human MYC promoter region are shown schematically at the top.
Lower panel, comparison of histone acetylation levels at human MYC
promoter regions L, K, N, and the murine MYC promoter region after
transfer of human chromosome 8 into mouse B78 cells.
doi:10.1371/journal.pone.0006109.g002
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Previous studies using MYC promoter-driven reporter genes
suggested that CTCF functions as a negative regulator of MYC
expression. To address whether removal of the CTCF sites would
also affect the level of MYC transcription in its native
chromosomal site, we determined the relative abundance of
human MYC mRNA by performing quantitative PCR in at least
four independent fusion clones for each mutation made. MYC
expression was normalized to expression of the endogenous
murine GAPDH gene. Average transcript levels of the endogenous
murine MYC gene varied less than twofold between the fusion
clones carrying the wildtype and mutant human chromosomes,
suggesting that the cell lines were kept under comparable
physiologic conditions (Figure 4A). In contrast, comparison of
the mean expression levels of the wildtype and mutated human
MYC alleles differed up to 6-fold. The deletion of both CTCF sites
in the mutant allele (CTCF-NA) significantly reduced the
expression of MYC [16.3%63.1 (mean6SEM, n=6)] relative
to the wildtype MYC allele (wt), whereas deletion of only the
CTCF binding site N within MINE (DCTCF-N) did not effectively
alter transcription (79.9%617.2, n=9). These results argue
against a role for CTCF in transcriptional repression of MYC
transcription. Removal of 2.3 kb of sequence encompassing the
entire MINE also reduced MYC mRNA levels. It is important to
note that this deletion removes multiple transcription factor
binding sites, including the FUSE binding element known to be
required for proper MYC expression [16]. Importantly, none of
these deletions completely ablated MYC transcription. In
concordance with previous reports [17], this argues against the
presence of a ‘masterswitch’ element necessary for domain
establishment and maintenance.
Figure 3. Acetylation status of wildtype and mutated MYC loci
on human chromosome 8. ChIP experiments were performed with
antibodies specific for H3K9/14ac using chromatin from mouse B78
clones carrying wildtype or mutated MYC loci on human chromosome
8. The binding sites for CTCF within the wildtype MYC promoter, the
positions of primers sets used to amplify regions (amplicons) J through
R, and the location of deletions introduced into the human MYC
promoter are shown above. Arrows indicate transcriptional start sites of
the P1 and P2 promoter. The fold enrichment of acetylated histone H3
was normalized to the signals from the endogenous mouse b-globin
gene promoter as an internal standard (mean6stdev, n=3).
doi:10.1371/journal.pone.0006109.g003
Figure 4. CTCF does not repress MYC expression and is
required for normal levels of MYC mRNA. Real time RT-PCR
analysis of the wildtype and recombinant MYC alleles residing on
human chromosome 8 in B78 cells. (A) The steady-state level of human
and mouse MYC RNA normalized to the endogenous mouse GAPDH
mRNA. Left panel shows the relative expression of human MYC as a
percentage of the expression detected in cells carrying the wildtype
(wt) MYC allele. This analysis was performed multiple times for each B78
cell line containing a human MYC allele (wt, n=7; DLg, n=8; DCTCF-N,
n=9;DCTCF-NA, n=6). Each clone was independently analyzed at least
twice, and each PCR reaction was performed in duplicate. The bars
indicate the mean value (6SEM) for all clones with the specific type of
mutation. The right panel shows the expression of the endogenous
murine MYC gene relative to the GAPDH gene. Mouse MYC gene
expression is expressed as a percentage of the expression that is
detected in cells carrying the human chromosome 8 with the wildtype
allele. The expression in each of the mutant cells lines varies less than
two-fold, indicating unaltered expression of the endogenous mouse
MYC gene. (B) Expression of wildtype and mutant human MYC genes in
starved (0 Hr) and serum-induced cells (1 Hr, 3 Hr, 9 Hr). RNA was
harvested prior to serum induction (0 Hr), and 1 hour, 3 hours, and
9 hours post serum induction and analyzed by real-time RT-PCR. MYC
mRNA levels were normalized to murine GAPDH mRNA levels. MYC
expression in serum-starved cells was set to 1, and RNA levels at 1, 3
and 9 Hr are expressed as fold-induction over 0 Hr timepoint.
doi:10.1371/journal.pone.0006109.g004
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MYC expression is highly responsive to growth factor signaling.
While expression of MYC is virtually absent in serum-starved cells,
its expression is induced 2–3 hours following addition of serum,
and returns to a basal level after 9 hours. To determine whether
the mutated human MYC alleles behave in a manner consistent
with the normal MYC gene, we monitored induction of
transcription at both the murine and human MYC genes in
response to serum. B78 lines containing the wildtype and mutant
human MYC alleles were starved for 24 hours, and the levels of
human MYC mRNA were measured by quantitative PCR relative
to the murine GAPDH gene before (0 hr) and at one, three and
nine hours following addition of serum (Figure 4B). The serum-
induced levels of MYC RNA (1 hr, 3 hr, 9 hr) were normalized to
the RNA level before the addition of serum (0 hr). After addition
of serum, MYC RNA levels in cells containing the wildtype allele
increased 18-fold, and returned to a low steady-state level nine
hours after addition of serum. Thus, the human MYC locus
residing in mouse B78 cells is regulated by mitogenic signals
similar to human MYC alleles in their normal context.
Furthermore, removal of the CTCF binding sites at the MINE
(DLg and DCTCF-N) and at the P2-promoter (DCTCF-NA) does
not affect the ability of the human MYC allele to respond to serum
induction (Figure 4B), suggesting that CTCF binding sites N and A
are not necessary for the integration of multiple environmental
signals during growth factor stimulation.
CTCF deletion and epigenetic modifications at the
human MYC allele
The deletion of both CTCF sites N and A leads to reduced
expression of the human MYC gene, suggesting that CTCF is
required for maintaining high levels of transcriptional activity.
Previous analyses of partially methylated viral reporter constructs
demonstrated that methylation of genes within promoter-proximal
regions and transcription start sites impair the efficiency of
transcription initiation [18]. Intriguingly, CTCF has been
reported to protect against de novo methylation of flanking
sequences [19–21]. To test whether the decrease in MYC
transcription at DCTCF-NA alleles in a cell population correlates
with an increase in DNA methylation in the promoter region, we
used a previously published protocol to measure the level of
methylation within three promoter regions of the MYC gene [21].
In this assay, promoter regions of the human MYC gene are
amplified with PCR using specific primer pairs CM1, CM2, and
CM3 after treatment of genomic DNA with methylation-sensitive
restriction enzymes (Figure 5). Successful PCR amplification
indicates cytosine methylation; in contrast, a failure to amplify
genomic DNA indicates unmethylated cytosine residues. Genomic
DNA digested with Eco RI for which no restriction sites exist in
the amplified regions was used as a reference. The methylation
status of the CTCF site N within MINE (CM2) and its neighboring
sites (CM1 and CM3) in the MYC locus were evaluated first.
Similar to previous observations [21], CpG residues in the AciI
sites within CM1 were methylated in wildtype MYC alleles, as
revealed by successful PCR amplification of this region. In
contrast, the AciI sites within genomic regions CM2 and P2
surrounding the CTCF site N and A, respectively, were
hypomethylated (Figure 5). Partial methylation was observed in
region CM3 in all cell lines, consistent with earlier reports [21].
When CTCF site N is deleted (DCTCF-N), DNA methylation in
CM2 increases while the P2 promoter region remains largely
unaffected. In contrast, deletion of both sites N and A increases
DNA methylation in both regions, as indicated by successful
amplification of these regions after digestion with the restriction
enzyme Aci I. These results demonstrate that lack of CTCF
binding at the MINE and the P2 results in a significant increase in
DNA methylation at these sites. Together, our data suggest that
CTCF binding at the MYC gene is required for high-level MYC
expression. In the absence of CTCF binding, CpG residues at the
P2 promoter region become methylated, reducing the ability to
recruit transcription initiation complexes.
Discussion
The zinc-finger protein CTCF is essential for the activity of
most mammalian insulators and is thought to protect genes from
unscheduled transcriptional activation by neighboring regulatory
elements. Insulator activity is sometimes paired with barrier
activity, which can prevent silencing of gene loci by inhibiting the
spread of heterochromatin. In this study, we examined the role of
CTCF binding sites within the MYC insulator element MINE in
the context of its native position in human chromosome 8. In
transgene experiments, MINE provides efficient insulator and
barrier function when inserted into reporter gene constructs [7].
A global analysis of CTCF binding across the genomes of three
different cell types identified a significant enrichment of CTCF sites
at domain boundaries where histone modifications typical for
transcriptionally active and inactive chromatin are juxtaposed [22].
Similarly, the CTCF site N of the human MYC gene is located
2.4 kb upstream of the MYC promoter at the intersection of
transcriptionally active and inactive chromatin [7]. These findings
suggest that CTCF may be involved in chromatin barrier function.
However, deletion of CTCF sites N and A in the MYC promoter
region has no effect on the level or extent of histone H3 acetylation
inthisdomain(Figure3).Consistentwiththisresult,previousstudies
at the endogenous mouseb-globinlocus have shown that deletion of
the CTCF binding site within the 39HS1 element has no effect on
histone acetylation levels at the beta major gene [23]. In contrast, a
reduction of histone acetylation upon deletion of the CTCF binding
motif has been observed in episomal reporter genes that contain a
cHS4 insulator element between enhancer and promoter [24].
While the exact reason for this discrepancy remains unknown, these
observations emphasize that CTCF’s function is strongly context-
dependent. Thus, in order to fully understand the impact of CTCF
on gene expression functional studies should ideally be performed in
the normal genomic locale of a given gene.
Our analysis of CTCF activity at the human MYC gene in the
context of human chromosome 8 surprisingly indicated a
requirement for CTCF for high-level expression of the MYC
gene. While the removal of a single CTCF site showed little
influence on MYC expression, deletion of both sites N and A led to
a decrease in MYC expression. This result suggests that deletion of
CTCF binding at site A is important for full level expression of the
human MYC gene. However, it is important to note that the
59 bp deletion downstream of the P2 transcriptional start site may
have affected binding of neighboring regulatory factors or their
relative spacing to each other. Although we are not aware of
reports describing transcription factor binding within the deleted
region of our DCTCF-NA mutant, we cannot rule out the
possibility that the deletion of CTCF has no effect at all on
transcriptional activity and that observed effects are due to
displacement of factors other than CTCF. Nevertheless, our results
are inconsistent with the previously reported role for CTCF as a
repressor of MYC activity that has been observed with transiently
transfected MYC reporter constructs in the presence of high levels
of CTCF [6]. The discrepancy between these two results is likely
MYC Insulator Element
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different experimental approaches. The essential role for CTCF in
nuclear organization and inter/intrachromosomal interactions
might affect the localization of transfected templates and
chromosomal regions in different nuclear compartments. Thus,
the previously identified multi-functional activities of CTCF in
transcriptional activation and repression may be a consequence of
the tethering of reporter genes to different nuclear loci.
The decrease of MYC transcriptional activity upon deletion of
CTCF binding sites correlates with an increase in the frequency of
methylation at CpG residues, consistent with earlier reports of a
role for CTCF in the establishment of DNA methylation free
domains [2,25–27]. The deletion of CTCF binding sites N and A
in the mutant DCTCF-NA allele leads to a significant decrease in
transcriptional activity (less than 20% of the wild type human
MYC allele) and correlates with an increase in methylation at the
CM2 and P2 sites. Despite an increase in DNA methylation,
hyperacetylated histones are still detectable in these cell lines.
Although examples of transcriptionally active genes with coexist-
ing histone acetylation and local DNA methylation have been
reported [28], this observation may also reflect heterogeneous
MYC expression in distinct subsets of cells in our mutant lines.
Additional studies using positive selection markers will be required
to distinguish between these possibilities.
The increase of local DNA methylation upon deletion of CTCF
sites is consistent with previous reports describing a role for CTCF
in maintaining DNA methylation-free domains [20,21,25,27,29].
While the exact role of CTCF in protecting CpG residues from
methylation is unknown, the previously reported CTCF-mediated
activation of poly(ADP-ribose)-polymerase (PARP1) provides an
intriguing link to its role in inhibition of DNA methylation
(reviewed in [30,31]).
In summary, our results demonstrate a role for CTCF in the
maintenance of MYC gene expression. While our data are
inconsistent with a role for CTCF in transcriptional suppression of
MYC, the controversial findings of the diverse functions of CTCF
may be due to its role in nuclear organization and long-range
interactions. CTCF may mediate transcriptional activation,
suppression, and insulation through its ability to form inter- and
intrachromosomal chromatin loops. The previous discovery of co-
localization of CTCF and cohesin across the mammalian genome
may provide a basis for the functional interplay between nuclear
organization and regulation of gene expression [32–35].
Materials and Methods
Cell lines and culture conditions
DT40[h8n] is a derivative of the chicken B cell-line DT40, and
harbors a single intact human chromosome 8 containing a
Figure 5. Deletion of CTCF binding sites protects the MYC
promoter from DNA hypermethylation. Top, scheme of DNA
methylation analysis in the MYC promoter region. AciI restriction
enzyme sites across the 2.5 kb human MYC 59 region are indicated by
filled squares. Positions of CTCF binding sites N and A, and of amplified
regions using primer pairs CM1 to 3 [21] and P2 are indicated. DNA of 4
different clones for each allele (wt, DCTCF-N, DCTCF-NA) was digested
with the methylation-sensitive restriction enzyme Aci I (A) or EcoR I (RI).
Amplification of EcoR I-digested DNA serves as a positive control, and
indicates the efficiency of PCR amplification. The level of amplification
of Aci I-digested DNA indicates gain of DNA methylation in the tested
region. While CM1 and CM3 regions show complete or partial
methylation, CM2 and P2 regions are unmethylated in the wildtype
human MYC allele. Deletion of CTCF sites N or N+A leads to DNA
methylation.
doi:10.1371/journal.pone.0006109.g005
MYC Insulator Element
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Dulbeccos’s modified Eagle’s media (DME) supplemented with
10% fetal calf serum/1% chicken serum, 10% tryptone phosphate,
and selection media (1 mg/ml G418). The murine melanoma cell
line B78 was propagated in DME supplemented with 5%
Fetalplex (Geminibiosources, Atlanta). To select for the presence
of neo
r-tagged human chromosome 8 in hybrid cell-lines [B78(h8n-
wt), B78(DLg), B78(DCTCF-N), B78(DCTCF-NA)], cells were
cultured in 0.5 mg/ml G418.
DNA transfections
1.5–3.0 pmol linearized plasmid was introduced into cells by
electroporation as described [15]. Electroporated cells were
subsequently selected with 2 mg/ml hygromycin or with
1.5 mg/ml L-histidinol and 1 mg/ml G418 for 14–20 days. Cell
lines with properly integrated hygromycin
r selection cassettes were
transiently transfected with CRE-recombinase/GFP-expression
plasmid introduced by electroporation. After establishing cell lines
from single GFP positive cells, the successful excision of the
selection cassettes by CRE was analyzed by selection of cells in
hygromycin or histidinol. Correct homologous recombinant events
were identified by PCR and Southern hybridization.
Transfer of human chromosome 8
To transfer human chromosomes (containing either wt, DLg,
DCTCF-N or DCTCF-NA MYC alleles) from DT40 into B78
cells, we used a suspension-monolayer fusion protocol [36] to
generate whole-cell fusions between donor cells (e.g. DT40[h8n]
(neo
R, ouabain
S) and recipient B78 cells (neo
S, oubain
R)). Hybrid
clones were selected in 0.5 mg/ml G418 and 20 mM ouabain. The
intactness of the human chromosomes residing in B78 hybrids was
assessed by sequence-tagged site (STS) marker PCR analysis (STS-
PCR primer pairs for human chromosome 8 are available upon
request) and fluorescent in situ hybridization (FISH) karyotyping
using normal human fibroblast genomic DNA as a probe. Human
DNA was labeled with biotin-14-dATP and detected with FITC-
avidin as described [37]. Slides were counterstained with DAPI
and examined with an epifluorescence microscope. Clones that
carried an intact copy of human chromosome 8 in a non-
rearranged form were used for further analysis of human MYC
expression.
Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed essentially as described previously
[7]. Chromatin was cross-linked in the presence of 1%
formaldehyde for 3 min at room temperature. After the addition
of glycine to a 0.125 M final concentration, cells were washed in
ice-cold phosphate-buffered saline containing protease inhibitors,
pelleted, resuspended in sodium dodecyl sulfate (SDS) lysis buffer
(1% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1), 16protease
inhibitor cocktail, and 10 mM butyrate), and sonicated 15 times
for 30 s each at setting 6.5 in a Branson sonicator with a microtip.
The DNA length ranged from 200 bp to 800 bp. After
centrifugation to remove cell debris, the whole-cell extract was
diluted 10-fold with ChIP dilution buffer (1% Triton X-100,
2 mM EDTA, 20 mM Tris-HCl [pH 8.1], 150 mM NaCl, 16
protease inhibitor cocktail and 10 mM butyrate). This chromatin
solution was cleared before immunoprecipitation using protein A
agarose slurry and normal rabbit serum to reduce nonspecific
background. Anti-acetylated histone H3 or anti-CTCF antibody
(06-599 and 06-917, Upstate Biotechnology) was added, and the
mixture was incubated overnight at 4uC. Immune complexes were
collected by addition of 25 mL protein A agarose slurry that had
been preincubated with bovine serum albumin and salmon sperm
DNA. After incubation at 4uC for 2 hours, the agarose beads were
washed several times as described [38]. DNA recovered from
immunoprecipitations was analyzed by duplex PCR using MYC-
specific primers and reference primers (b-globin) (primer sequences
available upon request) in the presence of [32P]dCTP. The fold
enrichment in each immunoprecipitation reaction was determined
by calculating the ratio of the signal obtained with MYC primers
to that of the reference primers.
Quantitative estimation of mRNA by Real Time PCR
analysis
Synthesis of cDNA was carried out according to the
manufacturers instructions (Qiagen) using 1 ug of total RNA.
Reverse transcription was carried out at 37uC for one hour. Real
Time PCR reactions were performed in 20 ml volume on an ABI
Prism-7000 (Applied Biosystems), in accordance with the recom-
mended protocol. TaqManH-based (Applied Biosystems) experi-
mental protocols were used to determine the expression of murine
GAPDH (Mm99999915_g1), murine MYC (Mm00487803_m1),
and human MYC (Hs00153408_m1). The TaqMan Universal
PCR Master Mix
TM protocol was used with each probe according
to the manufacture’s instructions. Each PCR was carried out in
duplicate to control for PCR variation. The relative abundance of
each target was calculated using the cycle threshold (Ct) values,
using the formula 2
2CT. The relative expression of each target was
normalized to murine GAPDH, using the formula x=2
2DDCt,
where x equals the fold difference in the amount of RNA between
the wild type and the deleted mutation clones (DDCt=DCtwt 2
DCtdeletion mutant and DCtwt=Ct c-myc2 CtGAPDH). Each calcula-
tion was normalized to murine GAPDH and then expressed as a
percentage of the wild type calculation.
DNA Methylation Analysis
Genomic DNA was extracted according to manufacturer’s
instructions and resuspended in TE buffer (DNAeasy
TM, Qiagen).
For each sample, 1 mg DNA was digested with HpaII, AciI, or
EcoRI. 100 ng digested DNA was PCR amplified using site-specific
primers (CM1-4) as described [21]. In addition, three primer sets
were used to analyze the MINE CTCF region (F73/R266):
GCCATTACCGGTTCTCCATA/CAGGCGGTTCCTTAAA-
CAA; CM(OuS)/R596: CCCGCGTTTGCGGCAAA/CAGCT-
CAGCGTTCAAGTGTT; and CM(InS)/R596: GGTCCCT-
CGAAGAGGTTCAC/CAGCTCAGCGTTCAAGTGTT) and
one set the P2-CTCF site (F2444/R2611: GGGATCGCGCT-
GAGTATAAA/CCTATTCGCTCCGGATCTC). At least three
different independent clones were studied for each mutation.
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